Filing search / Incannex Healthcare Limited / "Extraction"

S-1/A

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

patent applications to the Incannex patent portfolio. These patents cover all aspects of cannabinoid drug development including extraction, formulation

S-1

IXHL Incannex Healthcare Limited

3 Jul 24

IPO registration

6:29am

cover all aspects of cannabinoid drug development including extraction, formulation and methods of use. Competition We are targeting indications

20-F

2022 FY

IXHL Incannex Healthcare Limited

28 Oct 22

Annual report (foreign)

6:31am

development including extraction, API modification, formulation and methods of use. Competition We are targeting indications that have no registered

6-K

EX-99.1

nbtu2r2mta

9 Aug 22

Report of Foreign Private Issuer

6:01am

6-K

EX-99.3

4bgdh8yaiqv

12 May 22

Report of Foreign Private Issuer

9:25am

6-K

EX-99.1

eyeq12rphpk29y 41

12 May 22

Report of Foreign Private Issuer

9:25am

6-K

EX-99.1

m1ykdwhf

4 Apr 22

Incannex to Acquire APIRx Pharmaceuticals USA, LLC

6:07am